M
MerLion Pharmaceuticals
Researches and develops drugs based on natural products
About MerLion Pharmaceuticals
Merlion Pharmaceuticals is a biotechnology company dedicated to the development of innovative antibiotics aimed at addressing the growing threat of bacterial infections in both humans and animals. The company operates in the pharmaceutical and biotechnology sector, focusing on creating solutions for complex urinary tract infections (cUTI), ear infections, and biodefense against biothreat agents. Merlion's business model revolves around research and development, clinical trials, and regulatory approvals to bring their antibiotic candidates to market. Revenue is generated through the commercialization of approved drugs, partnerships with defense agencies, and collaborations with healthcare institutions. Key clients include hospitals, veterinary clinics, and government defense agencies. The company has achieved significant milestones, including US FDA and Health Canada approval for their finafloxacin-based treatments. Merlion's strategic partnerships, such as with the UK Defence Science and Technology Laboratory and the US Defense Threat Reduction Agency, further bolster their market position.
Source: Dealroom company dataNews
Open roles
MerLion Pharmaceuticals in the Berlin ecosystem
The MerLion Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Aravis Ventures
Novartis Venture Fund- LALacuna
ZKB - Zürcher Kantonalbank
Series B and later3 investors entered at this stage
- HEHeidelberg Capital Private Equity
Bio*One Capital- AEAurelia Private Equity
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MerLion Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MerLion Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

